Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Pfizer's Missed Megadeal Sparks the Dow's Rise

The market opened the week on an upbeat note, with the major stock indices all modestly on the upswing. The Dow Jones Industrial Average (DJINDICES: ^DJI  )  was up more than 45 points as of 2:35 p.m. EDT. Big Pharma's Pfizer (NYSE: PFE  ) has led the Dow's gain so far today, with the stock climbing 2% on reports of talks of a pharmaceutical megadeal with rival drugmaker AstraZeneca (NYSE: AZN  ) . Earnings season pushes on across the market, and outside of the Dow, Halliburton (NYSE: HAL  ) has jumped 3.1% to rank among the top large-cap stocks on the day. Let's catch up on what you need to know.

Pfizer's drive for a deal
Pfizer's talks with AstraZeneca about a mammoth merger have been the talk of the health-care sector today, even as talks never moved beyond informal discussions, according to the U.K.'s Sunday Times. Pfizer is in the hunt to bolster its drug pipeline and buoy revenue growth after the patent expiration of former top-selling cholesterol drug Lipitor. The rumored bid of about $100 billion for AstraZeneca would be predicated partly on the strength of the British company's cancer drug pipeline. However, Pfizer's rival turned down the offer and will press forward with its own effort to stave off upcoming patent expirations as it searches for revenue growth.

AstraZeneca's stock was up 8.7% so far on the day, but could such a merger help these two pharma giants? AstraZeneca is on course to lose patent protection on two of its top-selling drugs, Nexium and Crestor, in coming years, with the former to face its day of reckoning in 2014. The company has made several acquisitions of its own recently to keep its pipeline stocked, but AstraZeneca's leadership still sees falling revenue ahead. Pfizer, meanwhile, has managed to bounce back from Lipitor's loss behind other rising drugs, but the company's pipeline, while boasting 26 drug programs in phase 3 trials or later as of early November, lacks many candidates viewed as potential star treatments. According to Bloomberg, Pfizer holds about $69 billion worth of untaxed cash outside of the U.S., so don't expect the company to be done searching for big deals to provide a shake-up for eager investors.

Around the Dow today, Disney  (NYSE: DIS  )  has fallen to the bottom of the blue-chip index, losing 1%. Disney's stock has thrived lately, picking up 29% over the past year, so with little news out from the company it's likely that investors have taken profits from shares' rise. However, don't be swayed by the run-up: Disney looks like a long-term blue-chip winner. The company's sales across its business divisions, particularly its media networks group, its largest by revenue, have performed very well as of late. Box-office revenue continues to soar, with animated feature Frozen becoming the largest international animated hit of all time this past weekend by taking in nearly $730 million abroad. Disney's stock might be falling today, but this winner shouldn't be down for the long term.

Meanwhile, Halliburton is making waves today for its own better than expected quarterly earnings results. The oil-field services company reported a modest climb in year-over-year revenue to $7.3 billion for its most recent quarter. That, along with its $0.73 per-share earnings result, topped analyst expectations. Halliburton projects that its North American margins should rebound as prices rise in the near future. The company has made a successful international push as well, with 13% revenue growth in its Middle East and Asia segment in its most recent quarter. Increased drilling both at home and abroad bodes well for this energy supplier, and while Halliburton's steep 21% stock run-up year to date looks like a lot, this company's in prime position to capitalize on the ongoing shale boom.

Don't miss 3 more stock picks to ride America's energy bonanza
Halliburton's just one stock that's thrived on the American energy eruption. Record oil and natural gas production is revolutionizing the United States' energy position. Finding the right plays while historic amounts of capital expenditures are flooding the industry will pad your investment nest egg. For this reason, the Motley Fool is offering a look at three energy companies using a small IRS "loophole" to help line investor pockets. Learn this strategy, and the energy companies taking advantage, in our special report "The IRS Is Daring You To Make This Energy Investment." Don't miss out on this timely opportunity; click here to access your report -- it's absolutely free. 

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2922689, ~/Articles/ArticleHandler.aspx, 9/4/2015 3:03:44 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Dan Carroll

Dan began writing for the Motley Fool in 2012. He is a health care specialist who also follows the defense industry along with tracking the broader U.S. and international markets.

Today's Market

updated Moments ago Sponsored by:
DOW 16,066.90 -307.86 -1.88%
S&P 500 1,917.26 -33.87 -1.74%
NASD 4,672.09 -61.41 -1.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/4/2015 2:48 PM
^DJI $16073.05 Down -301.71 -1.84%
AZN $31.58 Down -0.66 -2.05%
AstraZeneca plc (A… CAPS Rating: ****
DIS $100.78 Down -1.21 -1.19%
Walt Disney CAPS Rating: *****
HAL $36.93 Down -1.15 -3.02%
Halliburton CAPS Rating: *****
PFE $31.27 Down -0.62 -1.94%
Pfizer CAPS Rating: ****